International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.14619275
Case Report
Correlation Of Prenatal Non-Stress Test with Perinatal Outcome in High-Risk Pregnancies
Published
Jan. 10, 2025
Abstract

Background: High risk factors during pregnancy adversely affect the maternal and foetal outcome increasing perinatal morbidity and mortality. Antepartum foetal surveillance can detect foetal hypoxia and acidemia before it becomes irreversible. Non- stress test (NST) is simple and cost-effective method of antepartum foetal surveillance. The objective of the study was to analyse the predictive value of NST in evaluating perinatal outcome in high-risk pregnancies. Materials and Method: Present study was carried out on 100 high-risk pregnant women with singleton pregnancy, of more than 34 weeks period of gestation.All participants underwent prenatal non-stress testing (NST). Based on the results, the cases were categorized into two groups: reactive NST and non-reactive NST. Perinatal outcomes were then assessed and compared between the two groups. Results: The common risk factorsobserved in our study were gestational hypertension (19%), anaemia (17%), hypothyroidism (14%), pre-eclampsia (10%), oligohydramnios (10%).Around 66% of the participants had reactive prenatal NST while 34% cases had non-reactive NST. Around 41% of the infants were low birth weight in non-reactive NST group while 13.6% in reactive group. Total 20.59% babies in non-reactive NST group had low Apgar at 5 minutes requiring NICU admission while 6.06% babies in reactive NST group had low Apgar requiring admission. Conclusion: Present study reveals significant difference in perinatal outcomes in highrisk cases with reactive and non-reactive NST. NST can be used for identifying the foetuses at risk of asphyxia and avoiding unnecessary delay in intervention. It can be used as single best screening in low resource centres to screen high risk antenatal cases.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
915 Views
482 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved